Akita H, Mukai Y, Kubo M, Wada H, et al. Reply to letter to editor by yinfang Wu, MM about our manuscript, "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer". Surgery 2025 Jan 25:109132. doi: 10.1016/j.surg.2024.109132.
PMID: 39864966